Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 Mar 03, 2015 4:30pm EST
Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and Webcast Feb 26, 2015 8:00am EST
Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare Conference Feb 25, 2015 4:39pm EST
Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare Conference Feb 19, 2015 8:00am EST
Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies Jan 13, 2015 6:45pm EST
Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors Dec 15, 2014 8:00am EST
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting Dec 09, 2014 8:00am EST
Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare Conference Dec 05, 2014 8:00am EST
